PERIPHERAL NEUROPATHY: ASSOCIATION WITH AGE AND SURVIVAL IN MULTIPLE MYELOMA PATIENTS


Silay K., Akinci S., Ulas A., Guney T., Yalcin A., Dilek I.

ACTA MEDICA MEDITERRANEA, cilt.32, sa.1, ss.123-126, 2016 (SCI İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 32 Konu: 1
  • Basım Tarihi: 2016
  • Doi Numarası: 10.19193/0393-6384_2016_1_19
  • Dergi Adı: ACTA MEDICA MEDITERRANEA
  • Sayfa Sayıları: ss.123-126

Özet

Objective: Multiple myeloma (MM) accounts for approximately 1% of all cancers and 10% of hematologic malignancies. Peripheral neuropathy (PN) is a common side effect of cancer therapy that can have an impact on quality of life and survivorship. PN may happen in MM due to adverse effect of chemotherapeutics, amyloidosis or as a part of paraneoplastic syndrome. The aim of this study is to evaluate the prevalence of peripheral neuropathy in multiple myeloma patients and its association with age and disease outcome.